Remove 2002 Remove Drug Development Remove Patient Experience Remove Telemedicine
article thumbnail

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

Founded in 2002, MGP has invested in more than 50 companies in these sectors. Technology investments focus on business and healthcare technology, targeting those ideas with quantifiable development risk and a rapid path to market. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.